Tools
Stock profile

HENRY SCHEIN INC (HSIC)

HSIC · Latest close $85.69 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$85.69
As of Nov 18, 2026
Tracked funds holding
4 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
3
vs previous quarter

HENRY SCHEIN INC (HSIC) is held by 4 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding and 3 funds trimming or exiting versus the previous quarter. Latest close $85.69 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Lyrical Asset Management · Greenlight Capital · Pzena Investment Management — 4 tracked funds hold HSIC. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

PVH CORP. /DE/ (PVH) · Cigna Group (CI) · Ferguson Enterprises Inc. /DE/ (FERG) · TE Connectivity plc (TEL) · GENUINE PARTS CO (GPC) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Lyrical Asset Management1.55%1,467,351TRIMMED (-5.0%) Q3 filed Nov 13
Greenlight Capital1.54%718,550ADDED (+19.9%) Q3 filed Nov 16
Pzena Investment Management0.21%860,733TRIMMED (-3.0%) Q3 filed Oct 30
Southeastern Asset Management0.07%17,038HELD Q3 filed Nov 16
First Pacific Advisors——EXITED

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -1.9% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

90.8660.882024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding562 of 8,857 filers
Long-only filers among them562
Change vs 2026 Q1+11 net · 531 entered · 520 exited
Shares reported, all filers122,668,376
Reported value, all filers$10.1B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryWholesale-Medical, Dental & Hospital Equipment & Supplies (SIC 5047)
Revenue · FY2025$13.2B
Net income · FY2025$398.0M
Total assets · FY2025$11.2B
Shares outstanding111,446,542
Market cap (at latest close)$9.5B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 27, 2026.

Short interest

Shares short · Oct 15, 20269,005,470
Share of shares outstanding8.08%
Days to cover7.02

Shares short at recent settlements — Jul 31, 2026: 6.3M · Aug 14, 2026: 6.9M · Aug 31, 2026: 8.1M · Sep 15, 2026: 7.6M · Sep 30, 2026: 8.3M · Oct 15, 2026: 9.0M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 27, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 48 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 27, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 14, 2026Stanley M. BergmanFormer Affiliate35,257$3.2MAug 14, 2026SEC filing
Jun 30, 2026HERRING JOSEPH LFormer Director28,791$2.4MJun 30, 2026SEC filing
Jun 16, 2026Stanley M. BergmanAffiliate16,933$1.4MJun 16, 2026SEC filing
Mar 19, 2026Popeck Thomas COfficer1,355$98.6KMar 19, 2026SEC filing
Mar 10, 2026KUEHN KURT PDirector2,844$224.6KMar 10, 2026SEC filing
Mar 5, 2026LASKAWY PHILIP ADirector2,844$228.5KMar 5, 2026SEC filing
Mar 4, 2026MLOTEK MARK EOfficer5,925$478.7KMar 4, 2026SEC filing
Mar 2, 2026Stanley M. BergmanCEO, Chairman43,812$3.6MMar 2, 2026SEC filing
Feb 27, 2026Stanley M. BergmanCEO, Chairman10,785$878.7KFeb 27, 2026SEC filing
Feb 26, 2026Stanley M. BergmanOfficer, Director43,046$3.5MFeb 26, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Mar 10, 2026SCHEDULE 13D/A+8.4% (close Mar 11, 2026 → Nov 17, 2026)

Reference close is the first trading day after the filing (Mar 11, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 6, 2026FMR LLCSC 13G7,553,900.886.6%Jun 30, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G7,302,6606.4%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Mar 10, 2026KKR Hawaii Holdings L.P.SC 13D/A15,263,66213.3%Mar 9, 2026SEC filing
Dec 9, 2025KKR Hawaii Holdings L.P.SC 13D/A15,263,66213.0%Dec 7, 2025SEC filing
Dec 3, 2025The Vanguard GroupSC 13G/A12,036,33610.2%Nov 28, 2025SEC filing
Nov 6, 2025KKR Hawaii Holdings L.P.SC 13D/A15,263,66213.0%Nov 4, 2025SEC filing
Oct 31, 2025SC 13G/A———SEC filing
Oct 30, 2025The Vanguard GroupSC 13G/A12,000,7769.9%Sep 30, 2025SEC filing
Aug 15, 2025KKR Hawaii Holdings L.P.SC 13D/A15,263,66212.6%Aug 13, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Wholesale-Medical, Dental & Hospital Equipment & Supplies (SIC 5047). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 169 Lobbying Disclosure Act filings named this company as client, 2000–2026; most common issues: Health Issues (87), Medicare/Medicaid (55), Taxation/Internal Revenue Code (12).

Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

· Earnings Stability — Small earnings swings and almost no loss years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Key figures

· Cash Flow (FCF) — Latest FCF: $573.0M · FCF yield: 5.5% · Positive FCF years: 3

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.72 · Operating cash flow: $712.0M · Net income: $398.0M

· Shareholder Yield — Shareholder yield: 8.1% · of which dividends: 0.0% · of which buybacks: 8.1%

· Earnings Stability — Earnings variation (CV): 0.21 · Loss years (of 10): 0 · Latest net income: $398.0M

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together1100.0%+23.2%+4.9%+18.3%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold HSIC — ranked by lift, the co-holding pattern described in Methodology: PVH CORP. /DE/ (PVH) · Cigna Group (CI) · Ferguson Enterprises Inc. /DE/ (FERG) · TE Connectivity plc (TEL) · GENUINE PARTS CO (GPC) · ARROW ELECTRONICS, INC. (ARW) · RESIDEO TECHNOLOGIES, INC. (REZI) · WESCO INTERNATIONAL INC (WCC).

6 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 16, 20267.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing
Nov 3, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Oct 8, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

PVH CORP. /DE/ (PVH) · Track Record: how the signals scored · Practice timing on HSIC

One email a week: the week’s new filings and research. Subscribe free

← HSBC  ·  HST →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.